1 October 2022 false Taxfiler 2024.5 09276399business:PrivateLimitedCompanyLtd2022-10-012023-09-30 092763992022-09-30 092763992022-10-012023-09-30 09276399business:AuditExemptWithAccountantsReport2022-10-012023-09-30 09276399business:FilletedAccounts2022-10-012023-09-30 092763992023-09-30 09276399business:Director12022-10-012023-09-30 09276399business:RegisteredOffice2022-10-012023-09-30 092763992022-09-30 09276399core:WithinOneYear2023-09-30 09276399core:WithinOneYear2022-09-30 09276399core:ShareCapitalcore:PreviouslyStatedAmount2023-09-30 09276399core:ShareCapitalcore:PreviouslyStatedAmount2022-09-30 09276399core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-09-30 09276399core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-09-30 09276399core:PreviouslyStatedAmount2023-09-30 09276399core:PreviouslyStatedAmount2022-09-30 09276399business:SmallEntities2022-10-012023-09-30 09276399countries:EnglandWales2022-10-012023-09-30 09276399core:PlantMachinery2022-10-012023-09-30 09276399core:MotorVehicles2022-10-012023-09-30 09276399core:PlantMachinery2022-09-30 09276399core:MotorVehicles2022-09-30 09276399core:PlantMachinery2023-09-30 09276399core:MotorVehicles2023-09-30 09276399business:OrdinaryShareClass12022-10-012023-09-30 09276399business:OrdinaryShareClass12021-11-012022-09-30 09276399business:OrdinaryShareClass22022-10-012023-09-30 09276399business:OrdinaryShareClass22021-11-012022-09-30 09276399business:OrdinaryShareClass32022-10-012023-09-30 09276399business:OrdinaryShareClass32021-11-012022-09-30 09276399business:AllOrdinaryShares2022-10-012023-09-30 09276399business:AllOrdinaryShares2021-11-012022-09-30 092763992021-11-012022-09-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 09276399 (England and Wales)
Wyvern Pharma Ltd Filleted accounts for the year ended 30 September 2023
Wyvern Pharma Ltd Filleted accounts Contents
Page
- 2 -
Wyvern Pharma Ltd Company Information for the year ended 30 September 2023
Director
Ahmed Altaf Zackaria
Company Number
09276399 (England and Wales)
Registered Office
Wyvern Pharmacy 81 Abbey Street Accrington BB5 1EH England
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Wyvern Pharma Ltd Statement of financial position as at 30 September 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
38,437 
1,219 
Current assets
Inventories
9,500 
9,805 
Debtors
43,972 
48,152 
Cash at bank and in hand
45,404 
- 
98,876 
57,957 
Creditors: amounts falling due within one year
(158,726)
(59,919)
Net current liabilities
(59,850)
(1,962)
Total assets less current liabilities
(21,413)
(743)
Provisions for liabilities
Other provisions
(232)
(232)
Net liabilities
(21,645)
(975)
Capital and reserves
Called up share capital
2 
4 
Profit and loss account
(21,647)
(979)
Shareholders' funds
(21,645)
(975)
For the year ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 17 September 2024 and were signed on its behalf by
Ahmed Altaf Zackaria Director Company Registration No. 09276399
- 4 -
Wyvern Pharma Ltd Notes to the Accounts for the year ended 30 September 2023
1
Statutory information
Wyvern Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 09276399. The registered office is Wyvern Pharmacy, 81 Abbey Street, Accrington, BB5 1EH, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
15% reducing balance
Motor vehicles
20% straight line
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
Pension costs
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
- 5 -
Wyvern Pharma Ltd Notes to the Accounts for the year ended 30 September 2023
4
Tangible fixed assets
Plant & machinery 
Motor vehicles 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 October 2022
1,487 
- 
1,487 
Additions
- 
46,751 
46,751 
At 30 September 2023
1,487 
46,751 
48,238 
Depreciation
At 1 October 2022
268 
- 
268 
Charge for the year
183 
9,350 
9,533 
At 30 September 2023
451 
9,350 
9,801 
Net book value
At 30 September 2023
1,036 
37,401 
38,437 
At 30 September 2022
1,219 
- 
1,219 
5
Inventories
2023 
2022 
£ 
£ 
Finished goods
9,500 
9,805 
9,500 
9,805 
6
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
VAT
3,429 
4,442 
Trade debtors
39,580 
37,910 
Accrued income and prepayments
- 
686 
Other debtors
963 
5,114 
43,972 
48,152 
7
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Bank loans and overdrafts
- 
1,545 
Trade creditors
44,372 
57,627 
Taxes and social security
7,807 
560 
Other creditors
104,728 
99 
Loans from directors
312 
- 
Accruals
1,507 
88 
158,726 
59,919 
- 6 -
Wyvern Pharma Ltd Notes to the Accounts for the year ended 30 September 2023
8
Share capital
2023 
2022 
£ 
£ 
Allotted, called up and fully paid:
2 Ordinary shares of £1 each
2 
2 
- A Ordinary Shares of £1 each
- 
1 
- B Ordinary Shares of £1 each
- 
1 
2 
4 
9
Average number of employees
During the year the average number of employees was 6 (2022: 7).
- 7 -